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The actinobacteria Streptomyces wadayamensis A23, an endophitic strain, was recently 
sequenced and previous work showed qualitatively that the strain inhibits the growth of 
some pathogens. Herein we report the genome analysis of S. wadayamensis which reveals 
several antibiotic biosynthetic pathways. Using mass spectrometry, we were able to identify 
desferoxamines, several antimycins and candicidin, as predicted. Additionally, it was possible 
to confirm that the biosynthetic machinery of the strain when compared to identified known 
metabolites is far underestimated. As suggested by biochemical qualitative tests, genome encoded 
information reveals that the strain A23 has high capability to produce antibiotics.
Keywords: genome sequencing, genome mining, molecular networking, Streptomyces, 
antibiotic activity
Introduction
Streptomyces genera carry an extremely versatile 
group of biosynthetic machineries capable to produce 
complex molecules of medical, agricultural and economical 
significance. They are recognized as the most resourceful 
producers of molecules that present antibiotic activities.1 
The mutualism existing among several actinobacteria and 
plants, ants and other organisms also seemed to be a key 
element to the capability to produce such small molecules.2,3
Since the pioneers work in partial genome sequencing 
to a more recent and wide investment on whole genome 
sequencing, it became clear that the ability of Streptomyces 
and other actinobacteria to biosynthesize promising 
metabolites is underestimated.1,4 Recent developments on 
next generation sequencing revealed a diverse plethora of 
gene clusters encoding for cryptic targets. It became clear 
that by accessing sequences genome encoded it is possible 
to predict enzymatic functions and the hole of an entire gene 
cluster involved in secondary metabolites biosynthesis. 
Genome-mining tools have therefore opened a new 
and innovative avenue for natural products research.5 
When combined with bioinformatic tools, it contributes to 
envisage a global map of biosynthetic gene clusters (BGC). 
The possibility to connect genes to natural products enables 
to direct the discovery of novel molecules, for instance, 
metabolites as coelichelin,6 orfamide A7 and salinilactam8 
were found by searching programs guided by the prediction 
of physical-chemical properties, anticipation of precursors 
incorporation, manipulation of higher levels and pathway 
specific regulators, inactivation of biosynthetic genes and 
analytical evaluation, and by in vitro reconstitution.9-18
Driven by the current status of the genome to natural 
products programs we invested in the Whole Genome 
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Shotgun project of Streptomyces wadayamensis A23, 
an endophytic strain isolated from Citrus reticulata 
(tangerine).19 Biochemical qualitative tests showed that 
strain A23 inhibits the growth of Candida albicans 
pathogen, Bacillus megaterium, Neisseria meningitides 
strains, and multiresistant Staphylococcus aureus.20 Herein 
we report our preliminary results generated after genome 
annotation and mining of the WGS project. Annotation was 
critical to predict that S. wadayamensis has high capability 
to biosynthesize antibiotics. Experimental evaluation 
combined to powerful analytical tools revealed the 
production of several bioactive metabolites as anticipated 
by mining.
Experimental
Chemical and samples
Water was purified using a Milli-Q water purification 
system (Millipore). Beef extract, yeast extract, peptone 
and agar were purchased from Oxoid (Hampshire, UK). 
HPLC grade methanol was purchased from Tedia Brazil 
(Rio de Janeiro, Brazil). FeCl3.6H2O, HCl, chromeazurol S, 
hexadecyltrimethylammonium bromide (HTMS), PIPES, 
KH2PO4, NaCl, NH4Cl, KOH, glucose, D-mannitol, casein 
hydrolisate, MgSO4.7H2O, CaCl2, MnSO4.H2O, H3BO3, 
CuSO4.5H2O, ZnSO4.7H2O and Na2MoO4.2H2O were 
purchased from Sigma-Aldrich. The actinobacterium 
strain A23, identified as Streptomyces wadayamensis, was 
isolated from a population existing in the plant tissue of 
Citrus reticulata (tangerine).
Culture media
The media used in this work were vegetative N (peptone 
5 g L-1, soluble starch 20 g L-1, meat extract 2 g L-1, yeast 
extract 3 g L-1, soy bean meal 2 g L-1, CaCO3 1 g L-1, 
pH 7.0); A medium (peptone 4 g L-1, meat extract 4 g L-1, 
yeast extract 2 g L-1, soybean meal 2 g L-1, maltose 20 g L-1, 
dextrine 10 g L-1, pH 7.0); INA (soy bean meal 15 g L-1, 
CaCO3 5 g L-1, glycerol 30 mL L-1, NaCl 2 g L-1, pH 7.0); 
RA3 (peptone 2 g L-1, yeast extract 4 g L-1, malt extract 
10 g L-1, glucose 10 g L-1, glycerol 5 mL L-1, MgCl2.6H2O 
2 g L-1, pH 7); GPMY (potato starch 20 g L-1, yeast extract 
5 g L-1, malt extract 5 g L-1, glycerol 20 mL L-1, pH 7.0) 
AFMS (dextrose 20 g L-1, yeast extract 2 g L-1, soybean 
meal 8 g L-1, CaCO3 4 g L-1, NaCl 1 g L-1, pH 7.3); GYM 
(yeast extract 4 g L-1, malt extract 10 g L-1, glucose 4 g L-1, 
pH 7.0) and M8 (soluble starch 20 g L-1, meat extract 
2 g L-1, yeast extract 2 g L-1, glucose 10 g L-1, CaCO3 3 g L-1, 
pH 7.0).
Fourier transform ion cyclotron resonance mass 
spectrometry (FT-ICR-MS) sample preparation
A single colony of Streptomyces wadayamensis was 
selected and added to 1 mL of vegetative N medium (seed). 
The cell was grown for 24 h at 30 oC and 250 rpm. After this 
time, the seed medium was added in 100 mL of the culture 
medium described above. Streptomyces wadayamensis 
was cultivated for 7 days in 500 mL Erlenmeyer flasks on 
reciprocal shaker at the same conditions. The medium was 
centrifuged and the mycelium was separated. The broth was 
extracted three times with ethyl acetate. The organic layer 
was evaporated. 1 mg of the culture extract was dissolved in 
1 mL of methanol and centrifuged for 10 min at 13,000 rpm 
to remove any precipitate. This solution was used as stock 
solution from which aliquots of 100 µL were removed and 
diluted in 1 mL of methanol.
FT-ICR-MS analysis
The equipment  was  an  LTQ FT Ul t ra  7T 
(ThermoScientific) equipped with a nano-electrospray 
ionization (ESI) source (TriVersa NanoMate 100 system). 
Ionization was carried out both on the negative and positive 
ion mode on an m/z between 100 and 2000. The spectra 
generated were analyzed with the Xcalibur software.
Desorption electrospray ionization imaging mass 
spectrometry (DESI-IMS) sample preparation
For microbial IMS sample preparation, a 0.25 µL 
sample from a Streptomyces spore solution was inoculated 
on thin-layered agar. The antibiotic assay medium 2 
(1.5 g L-1 beef extract, 3.0 g L-1 yeast extract, 6 g L-1 peptone 
and 1.5% agar) was prepared by first placing a sterile 
microscope slides in a Petri dish, followed by the pouring 
of agar medium. The inoculated medium was incubated 
at 30 °C, and the Petri dish was sealed with parafilm to 
minimized premature dehydration. After the incubation 
period (48 h), the microscope slides were removed from 
the Petri dish, photographed and put in a vacuum desiccator 
for complete agar dehydration at room temperature. 
DESI-IMS analysis
IMS was performed using a Prosolia DESI source 
(Model OS-3201) connected to a Q Exactive Hybrid 
Quadrupole-Orbitrap. The DESI configuration was set 
with an emitter height of 2.5 mm, mass spectrometer inlet 
height of 0.1 mm, inlet to emitter distance of 3.8 mm, 
58° sprayed angle, 5.0 kV spray voltage, inlet capillary 
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temperature of 320 °C, 100 V S-lens, 160 psi ultra-pure 
nitrogen nebulizing gas pressure and a sprayed solvent of 
methanol in a 3.0 µL min-1 flow rate. Images were collected 
scaning from m/z 133-1500 with a step size of 200 mm, a 
scan rate of 741 µm sec-1 and a pixel size of 200 × 200 µm.
MS and tandem mass spectrometry (MS/MS) for network 
analyses
For analysis of Streptomyces wadayamensis A23 
metabolite profiles, cells cultures and medium were 
removed from microscope slides and extract with 0.5 mL 
methanol after DESI-IMS analysis. The extract were 
centrifuged for solid parts removal, and the remaining 
solution was analyzed by direct infusion ESI in a Thermo 
Scientific Q Exactive Hybrid Quadrupole-Orbitrap Mass 
Spectrometer. The MS/MS experiments were all conducted 
with 3.5 kV spray voltage, inlet capillary temperature of 
320 °C, 100 V S-lens in a 3.0 µL min-1 syringe flow rate.
Data analysis
The DESI-IMS data was converted into imaged files 
using the Firefly data conversion software (version 2.1.05)21 
and viewed using the BioMAP software (version 3.8.04).22 
For molecular network creation, the tandem mass data 
(.raw) were converted in mzXML using msconvert from 
ProteoWizard and the GNPS automated platform23 in 
default settings.24 In addition, Cytoscape 2.825 was used 
for molecular network visualization.
Results and Discussion
As previously described, the genome draft of 
S. wadayamensis A23 has near to 7 million base pairs, 
encoding 6006 protein-coding sequences with 73.5% 
GC content.19 The Illumina shotgun library produced 
7.8 million reads in a total of 2.4 GB data assembled to 
generate 180 contigs. Genome annotation was carried out 
using a customized pipeline and revealed several putative 
secondary metabolites encoded by S. wadayamensis.
The input of the genome data into the antibiotics 
& Secondary Metabolite Analysis SHell (antiSMASH) 
server (version 3.0.5)26 resulted in an output predicting 
the presence of 32 gene clusters codifying for secondary 
metabolites biosynthesis. Biosynthetic systems as terpene, 
nrps, bacteriocin-terpene, t1-pks, t3-pks, bacteriocin, 
nrps-t1pks, tiopeptide-lantipeptide, lantipeptide-nrps-t1-
pks, siderophore, ectoine, lassopeptide, lantipeptide and 
other clusters are apparently encoded in S. wadayamensis 
genome (Table S1). Crossing the output results from 
antiSMASH27 within the MIBiG (Minimum Information 
about a Biosynthetic Gene cluster) pipeline,28 it was 
possible to predict more accurately certain metabolites 
and/or the most likely class that the gene cluster fits as 
presented in Table 1. 
Table 1. Most significant gene clusters encoded in Streptomyces wadayamensis genome (antiSMASH-MIBiG output)a
Cluster overview Coordinates (nt location in 
the contig) Gene cluster type Predicted metabolite
Cluster 1 174778 - 225031 nrps-t1pks SGR PTMs BGC (100% of genes show similarity) 
frontalamides BGC (100% of genes show similarity)
Cluster 2 258744 - 285332 terpene hopene BGC (76% of genes show similarity)
Cluster 4 and 16 1 - 80422 
1 - 69344
t1pks FR-008 BGC (50% of genes show similarity) 
FR-008 BGC (95% of genes show similarity
Cluster 5 85376 - 126473 t3pks herboxidiene BGC (12% of genes show similarity)
Cluster 6 208192 - 240719 terpene-bacteriocin carotenoid BGC (54% of genes show similarity) 
isorenieratene BGC (54% of genes show similarity
Cluster 7 255844 - 300115 other indigoidine BGC (80% of genes show similarity) 
auricin deoxysugar moieties BGC (80% of genes show similarity)
Cluster 8 174427 - 195716 terpene albaflavenone BGC (100% of genes show similarity)
Cluster 15 75862 - 86260 ectoine ectoine BGC
Cluster 17 65097 - 139158 nrps-t1pks antimycin BGC (93% of genes show similarity)
Cluster 21 35751 - 96211 nrps mannopeptimycin BGC (48% of genes show similarity)
Cluster 22 18428 - 30248 siderophore desferoxamine B BGC (100% of genes show similarity)
Cluster 25 6543 - 28843 terpene germacradienol / geosmine synthase
Cluster 26 14854 - 29885 siderophore aerobactin IucA / IucC family protein
aNot all annotated gene clusters are represented in this chart.
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However, it is important to emphasize that, although 
the antiSMASH platform predicts 32 possible BGC, this 
actual number could be underestimated as the genome is 
organized in 180 contigs and some clusters are truncated 
(for example, both clusters 4 and 16 are complementary 
and correspond to the BGC of FR-008).
After in silico analysis, the metabolic profile of the ethyl 
acetate extracts from cultivation in several mediums was 
evaluated by FT-ICR-MS and Orbitrap in both the positive 
and negative ion modes using a m/z range between 100 and 
2000. To identify the most common ions present in the 
extracts, we performed a manual search in the dictionary 
of natural products (DNP),29 with near to 226000 structures 
from wide-ranging sources.
Although there is a difference in intensity for the signals 
in the chromatographic profile (Figure S1), almost the 
same set of ions were found in the conditions tested for 
fermentation (data not shown).
A careful evaluation of A medium pointed to an ion 
of m/z 601.3552 with attributed formula C27H48N6O9. 
Among the structures generated in the DNP database, we 
identified nocardamine, also known as desferoxamine E 
(Figure 1), a siderophore with high affinity for iron, 
which forms a complex that is reabsorbed by the cell via 
the ATP-dependent transport system.30 We had already 
observed the production of siderophores by qualitative 
tests on agar plates containing chrome azurol sulfonate.20 
Additionally, we performed direct DESI-IMS on an agar 
culture and observed another siderophore of same family, 
that is, the desferoxamine B of m/z 561.3640 (Figure 1).31
Both siderophores predicted by the gene cluster 22 
were therefore characterized by chemical/biological tests 
(chrome azurol) and MS/MS fragmentation patterns. 
The fragmentation of protonated desferoxamine E was 
mainly characterized by the neutral loss of a molecule of 
succinylcadaverine (200 Da, Figure S2).32 
Desferoxamine (MIBiG BGC 0000941) is a 
highly conserved gene cluster in Streptomyces genera 
(Figure 2). The antiSMASH output for Streptomyces 
wadayamensis A23 resulted in 10 different sequences 
deposited in databases that possesses high similarity 
within our query sequence (Streptomyces albus J107, 
Streptomyces sp. SM8, Streptomyces sp. PVA 94-07, 
Streptomyces sp. GBA 94-10, Streptomyces mutabilis 
TRM4554, Streptomyces wadayamensis A23 LGO A23 AS7, 
Streptomyces sp. JS01, Streptomyces griseus subsp. griseus 
NBRC 1335, Streptomyces griseus XylebKG-1). The 
gene cluster comprises a set of 5 main enzymes (5 to 9) 
with essential functions for the siderophore biosynthesis: 
siderophore biosynthetic enzyme (5), acetyltransferase (6), 
monooxygenase (7), pyridoxal-dependent decarboxylase (8) 
and siderophore-interacting protein (9).
A total of 6 product ions related to antimycins were 
also identified, which are part of a family of polyketides-
nonribosomal peptides already isolated from Streptomyces sp. 
exhibiting confirmed antifungal activity and predicted on 
gene cluster 17.33,34 The antimycins are biosynthesized by 
a mixed cluster nrps-t1pks and the main differences among 
them are located in the chains R1 and R2 positions, which 
corresponds to an aliphatic and fat acid chain, respectively, 
Figure 1. Siderophore desferoxamines B and E chemical structures.
Figure 2. Desferoxamine biosynthetic gene cluster from Streptomyces wadayamensis A23.
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and characterize the main losses observed by MS/MS 
(Table 2).33,34 Most of the product ions from antimycins 
fragmentation are common among all isoforms, e.g., m/z 
263, 245, 219, 191 and 161, however and fortunately, there 
is often one fragment (R1, Figure 3A) which is characteristic 
for each antimycins variant. Therefore, based on these 
product ions, the production of antimycin variants such as 
A11, A13, A14, A16 and A20 could be excluded from our 
samples. As some variants have the same precursor ions 
and the same characteristic product ions, the fragmentation 
pattern may correspond, for instance, to A1a or A1b, A12 
or A19, A8 or A17 (where R1 corresponds to distinct acyl 
chains in the structural isomers), therefore it is not possible to 
distinguish between then by MS spectrometry and additional 
analysis, such as NMR, would be necessary to discriminate 
the structural isomers.
The production of antimycins A1, A12 and/or 
A19 (C28H40N2O9) identified by the [M – H]– anion of 
m/z 547.2663; antimycin A4 (C25H34N2O9) of m/z 505.2202; 
antimycin A3 and/or A7 (C26H36N2O9) of m/z 519.2357; 
antimycin A2, A8 and/or A17 (C27H38N2O9) of m/z 533.2508; 
antimycin A10 and/or A15 (C29H42N2O9) of m/z 561.2832 
and antimycin A16 (C30H44N2O9) of m/z 575.2994 were 
accordingly confirmed by A23 strain in the cultivation 
conditions (Figure 3 and Figure S3).
The gene cluster codifying for antimycins in 
S. wadayamensis is 100% identical to the one described by 
Seipke et al.35 and fed in MIBiG platform (BGC0000958), 
Table 2. The antimycins PKS-NRPS hybrids variants and their ESI(−)-MS/MS characteristics
 
m/z (error) Antimycin R1 Characteristic product ion R2
505.2202 (1.07 ppm)
A4
a -COCH(CH3)2 87.0446 -(CH2)3CH3
b -COCH2CH2CH3 87.0446 -(CH2)3CH3
A20 -COCH3 43.0183 -(CH2)5CH3
519.2357 (0.94 ppm)
A3
a -COCH(CH3)CH2CH3 101.0602 -(CH2)3CH3
b -COCH2CH(CH3)2 101.0602 -(CH2)3CH3
A7
a -COCH(CH3)2 87.0446 -(CH2)2CH(CH3)2
b -COCH2CH2CH3 87.0446 -(CH2)2CH(CH3)2
533.2508 (0.34 ppm)
A2
a -COCH(CH3)2 87.0446 -(CH2)5CH3
b -COCH2CH2CH3 87.0446 -(CH2)3CH3
A8
a -COCH(CH3)CH2CH3 101.0602 -(CH2)2CH(CH3)2
b -COCH2CH(CH3)2 101.0602 -(CH2)2CH(CH3)2
A11 -COCH2CH2CH(CH3)2 115.0759 -(CH2)3CH3
A17 -COCH(CH3)CH2CH3 101.0602 -(CH2)4CH3
547.2663 (0.18 ppm)
A1
a -COCH(CH3)CH2CH3 101.0602 -(CH2)5CH3
b -COCH2CH(CH3)2 101.0602 -(CH2)5CH3
A12 -COCH2CH2CH(CH3)2 115.0759 -(CH2)2CH(CH3)2
A13 -COCH2CH2CH(CH3)CH2CH3 129.0915 -(CH2)3CH3
A19 -COCH(CH3)CH(CH3)2 115.0759 -(CH2)4CH3
561.2832 (1.47 ppm)
A10
a -COCH(CH3)CH2CH3 101.0602 -(CH2)3CH(CH3)CH2CH3
b -COCH2CH(CH3)2 101.0602 -(CH2)3CH(CH3)CH2CH3
A14 -COCH2CH2CH(CH3)CH2CH3 129.0915 -(CH2)3CH3
A15 -COCH2CH2CH(CH3)2 115.0759 -(CH2)5CH3
575.2994 (1.96 ppm) A16 -COCH2CH2CH(CH3)CH2CH3 129.0915 -(CH2)5CH3
Genome Mining of Endophytic Streptomyces wadayamensis Reveals High Antibiotic Production Capability J. Braz. Chem. Soc.1470
comprising the genes 1 to 16 in Figure 4. The modular 
polyketide synthase gene antD (gene number 5, module 3, 
Figure 4) carries a KS, AT, ACP and TE domain. According 
to the differences observed in R1 chains, it is possible to 
infer that the AT specificity is highly atypical with the 
incorporation of several acyl-CoAs subunits. 
The mining also indicated a possible metabolite 
described by the clusters 4 and 16 belonging to the 
FR-008 BGC, a complex polyene with high similarity to 
the candicidin gene cluster found in Streptomyces griseus 
IMRU3570 (Figure 5).36 Chen et al.36 originally described 
this metabolite and its gene cluster in 2003 and throughout 
this study it was possible to conclude that candicidin and 
FR-008 are identical compounds.
A meticulous search led us to find candicidin 
(m/z 1109.5784, C59H84N2O18, Figure 6) in the crude extract, 
Figure 3. (A) ESI(−) FT-ICR-MS of Streptomyces A23 crude extract (AFMS medium) showing deprotonated antimycin analogues; (B) MS/MS fragmentation 
pattern of the deprotonated antimycin A1a (note that this fragmentation pattern could be expected for A1b, A12 and A19 as well).
Figure 4. The organization of antimycins gene cluster in Streptomyces 
wadayamensis A23.
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which could be most likely, the compound responsible for 
C. albicans growth inhibition.36
An indication for the production of candicidin in 
S. wadayamensis was already anticipated in previous 
studies20 by the use of metabolic probes to promote 
dereplication. The KS-AT domains from FscB and FscD 
(gene numbers 17 and 20, respectively, Figure 7) were 
identified using this methodology. The candicidin gene 
cluster organization in the endophytic strain is 100% 
identical to the gene cluster description for FR-008 
(BGC0000061 in MIBiG repository).
To enhance the A23 dereplication, we performed the 
molecular networking analysis of A23 cultivation extracts, 
but no further known molecules were found. Interestingly, 
we were able to cross several information found by 
FT-ICR-MS and DESI-IMS. As molecular networking also 
Figure 5. Chemical structure of the complex polyene candicidin.
Figure 6. ESI(+) Orbitrap MS of Streptomyces A23 extract (A medium) showing the observed ions in the range m/z 1000-1200.
Figure 7. Candicidin gene cluster organization in the endophytic Streptomyces wadayamensis.
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enables clustering families of structurally related natural 
products by MS/MS fragmentation pattern analysis, and 
DESI-IMS is able to correlate molecules of same spatial 
distribution during the microorganism growth, it is possible 
therefore to establish a correlation within a related set of 
compounds that could share chemical similarities.24,37 Using 
molecular networking dereplication, we were able to find 
desferoxamine B (described in cluster 22) and their iron 
complex form (Figure 8),31 and we also tagged three other 
clusters of potentially unknown natural products (cluster 1: 
m/z 700.645; cluster 2: m/z 1193.38; cluster 3: m/z 912.627).
IMS experiments revealed that metabolites possibly 
described by the gene clusters from Table 1 and Table S1 
could be visualized over the agar media around the colony. 
A preliminary MS/MS analysis showed that the ion m/z 912 
seems to be a nonribosomal linear peptide (NRP) not yet 
described (Figure S4). We failed to find a similar pattern in 
networking or in dictionary of natural products. In total, we 
found three different compounds (m/z 884, 898, and 912) 
differing in 14 u (CH2) between each other from which is 
possible to observe a similar arrangement distribution over 
the agar media in IMS data.
Finally, mining the genome revealed gene cluster 
21, related to a NRPS responsible to mannopeptimycin 
biosynthesis (48% of the genes show similarity) produced 
by several strains of Streptomyces hygroscopicus. 
Mannopeptimycins are glycosylated cyclic hexapeptides 
(glycopeptides) first described as a complex mixture of 
compounds named AC98 and showed effective activity 
against Gram-positive bacteria (Figure 9).38 Its activity was 
also confirmed against methicillin resistant staphylococci 
and vancomycin resistance enterococci.39
The biosynthetic pathway for mannopeptimycins was 
described by Margavey et al.40 in 2006. Looking closely 
and performing blast and protein function comparison, it 
is possible to verify that the main genes mppA and mppB 
responsible for the hexapeptide core are 100% identical 
in S. wadayamensis A23 (genes 23 and 24 in Figure 10A) 
and S. hygroscopicus NRRL 30439, revealing similar 
operon type organization (Figure 10B). The most part of 
the right hand outside genes (except for mppM, mppN, 
mppX, mppY, mppZ, and mppZ1) are also identical in 
both strains. mppM and mppN correspond to isovaleryl 
transferases, responsible for the isovaleryl incorporation in 
the terminal O-linked mannose in mannopeptimycins γ, δ, 
and ε. The absence of these genes in the BGC codified by 
S. wadayamensis suggests that this strain could produce α 
or β-mannopeptimycins. The genes mppX, mppY and mppZ 
have unknown function and mppZ1 is a transcriptional 
regulator. The left hand side genes in Streptomyces 
wadayamensis codifies for a single major facilitator 
transporter (gene 22), while in the mannopeptimycin gene 
cluster used for comparison there are two genes (E and F) 
codifying for this function. In the MIBiG entry mppI and 
Figure 8. (A) Annotated molecular networking of orbitrap MS/MS fragmentation data acquisition from crude extract of Streptomyces A23 in 3 different 
growth times: 40 h (red nodes), 60 h (green nodes) and 90 h (yellow nodes). Compounds present in all experimental conditions are represented with blue 
nodes and other combinations in gray nodes; (B) superposed image showing the spatial distribution for m/z 912 over the medium around the microbial colony.
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mppH codifies for polyprenyl fosfo-mannosyl transferases, 
mppJ for a methyltransferase, mppG for a polyprenyl 
mannose synthase, mppD for a sugar binding protein and 
mppC for an acetyltransferase. For mannopeptimycin BGC 
from S. wadayamensis it is possible to describe several 
unknown function genes (labelled in grey) and two glucose 
specific phosphotransferase (genes 12 and 21) among 
others. Under the fermentation conditions we couldn’t 
identify the production of mannopeptimycin, but still the 
information is genome encoded and is under investigation.
All the molecules identified so far shows that Streptomyces 
wadayamensis A23 has a high capability to produce 
antibiotics. Still, we need to correlate the chemical entities 
with the biochemical activity prompted to inhibit the growth 
of pathogens as observed. Studies related to the unknowns 
metabolites produced by A23 strain are in progress.
Conclusions
The genome sequencing of Streptomyces wadayamensis 
A23 combined with gene annotation and mass spectrometry 
pattern evaluation revealed the strain is a promising producer 
Figure 9. Mannopeptimycins chemical structures.
Figure 10. (A) Mannopeptimycin gene cluster organization in Streptomyces wadayamensis A23 (adapted from antiSMASH output); (B) mannopeptimycin 
gene cluster organization in Streptomyces hygroscopicus NRRL 30439 (adapted from reference 37).
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of several secondary metabolites. As such tool improves 
the dereplication approach it was possible to observe the 
production of the siderophores deferoxamines B and E, 
several antimycins antibiotics and the polyene candicidin. 
These results open a wide field of research encompassing 
“from genome to natural products” as a promising strategy 
to find new biological and pharmacological targets. 
Supplementary Information
Supplementary Information (LC, LC-MS and MS/MS 
data) is available free of charge at http://jbcs.sbq.org.br.
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